CONJUPRI

This brand name is authorized in United States

Active ingredients

The drug CONJUPRI contains one active pharmaceutical ingredient (API):

1 Levamlodipine UNII 12WW9T2ITA - LEVAMLODIPINE MALEATE

Levamlodipine is the pharmacologically active isomer of amlodipine, a long-acting calcium channel blocker. It is used for the treatment of hypertension in adults and pediatric patients, to lower blood pressure. Read about Levamlodipine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CONJUPRI Tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C08CA17		C Cardiovascular system → C08 Calcium channel blockers → C08C Selective calcium channel blockers with mainly vascular effects → C08CA Dihydropyridine derivatives
Discover more medicines within C08CA17

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: US	FDA, National Drug Code	Identifier(s): 69101-512, 69101-525, 69101-550